Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Anticipated Size Of The Mammalian Cell Fermentation Technology Market Over The Five-Year Period 2025–2029?
The mammalian cell fermentation technology market size has observed swift growth in recent years. This market is expected to expand from $51.29 billion in 2024 to $57.37 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.9%. The drivers behind this historical growth include the escalating demand for biologics and biosimilars, a heightened focus on personalized medicine, increased production of biopharmaceuticals, and the rising need for scalable and effective cell culture methods.
The mammalian cell fermentation technology market is projected to experience substantial expansion over the upcoming years. By 2029, its valuation is predicted to reach $87.07 billion, exhibiting a compound annual growth rate (CAGR) of 11.0%. This growth during the projected period can be ascribed to several factors, such as the increasing occurrence of chronic diseases, greater investments by multinational corporations, wider implementation of advanced bioprocessing techniques, expanded funding for research and development into novel recombinant proteins, and a heightened demand for cancer therapies. Key trends anticipated for this period encompass innovations in cell culture technology, progress in bioreactor design, the development of next-generation bioprocessing solutions, the incorporation of multi-omics strategies, and automation driven by technology.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp
What Are The Key Drivers Of Growth In The Mammalian Cell Fermentation Technology Market?
The anticipated expansion in the mammalian cell fermentation technology market is propelled by the increasing need for biologics. These medical products, known as biologics, are derived from living organisms or their components and are frequently utilized in treating conditions such as cancer, autoimmune disorders, and infectious diseases. The rising demand for biologics is fueled by breakthroughs in biotechnology, their efficacy in managing prevalent chronic illnesses like cancer and autoimmune disorders, regulatory approvals, and heightened investment in research and development. Mammalian cell fermentation technology efficiently produces complex biologics, effectively addressing the escalating demand for personalized and targeted therapeutics. Its attributes of scalability, versatility, and capability to yield high-quality proteins stimulate innovation within the biopharmaceutical sector. For instance, in February 2024, the National Library of Medicine, a US-based medical library, reported that in 2023, the Food and Drug Administration (FDA) approved 55 new drugs, which included 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), representing a 50% increase compared to the 37 approvals in 2022. Consequently, the growing demand for biologics is a key driver for the growth of the mammalian cell fermentation technology market.
What Are The Emerging Segments Gaining Attention In The Mammalian Cell Fermentation Technology Market?
The mammalian cell fermentation technologymarket covered in this report is segmented –
1) By Type: Chinese Hamster Ovary Cell Fermentation; Human Embryonic Kidney Cell Fermentation; Baby Hamster Kidney Cell Fermentation; Murine Myeloma Cell Fermentation; Other Types
2) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Hormones; Enzymes; Other Applications
3) By End-Use: Biopharmaceutical Companies; Contract Research Organizations And Contract Development and Manufacturing Organizations; Academic And Research Institutes
Which Trends Are Impacting The Mammalian Cell Fermentation Technology Market?
Leading enterprises within the mammalian cell fermentation technology market are concentrating on advancing novel technologies, such as mammalian cell culture, to solidify their competitive standing. Mammalian cell culture serves as an essential instrument across diverse sectors, including biomanufacturing, scientific inquiry, and regenerative medicine, by enabling the creation of therapeutic proteins, vaccines, and functional cells or tissue analogs. For example, in June 2024, Syntegon, a biotechnology firm based in Germany, unveiled its new Modular Bioprocessing Platform (MBP) at Achema 2024, specifically engineered to address significant obstacles in biopharmaceutical manufacturing. This groundbreaking platform provides an exceptionally adaptable, fully integrated, and automated solution applicable to a broad spectrum of uses, encompassing microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The MBP’s modular architecture facilitates quicker delivery times and lower expenditures while upholding superior functionality and quality, in line with the “made in Germany” benchmark. Its pre-built cleanroom configuration positions all supporting technology outside the cleanroom area, boosting operational effectiveness and simplifying upkeep.
Who Are The Prominent Global Companies Shaping The Mammalian Cell Fermentation Technology Market?
Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Mammalian Cell Fermentation Technology Industry?
North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Mammalian Cell Fermentation Technology Market Report:
https://www.thebusinessresearchcompany.com/customise?id=16473&type=smp
Browse Through More Reports Similar to the Global Mammalian Cell Fermentation Technology Market 2025, By The Business Research Company
Cell Based Assays Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
Stem Cell Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report
Cellular Telephone Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model